Four Weeks in AI. What Changed, What It Means, and What Your Business Can Use.

What changed

What it means for strategy

Reassess work at the process level.

Tools that combine documents, data, coding, and actions create opportunities beyond faster drafting. A strategy team can evaluate whether preparing a competitor review, collecting evidence, or assembling a management brief can become a repeatable service. The strategic question is which responsibility creates value when completed more consistently.

Revisit the economics of routine work.

Lower-cost models make some high-volume applications worth testing again. Classifying requests, extracting fields, or producing short summaries may need different models from complex analysis. This supports a portfolio of approaches rather than selecting one model for every task.

However, model pricing is only part of the cost. Include integration, retries, supervision, corrections, and maintenance. A cheaper response that requires additional checking can cost more to use.

Review the build-or-buy decision.

AI-assisted development expands the scope for small internal tools. A purpose-built intake form, tracker, or reporting utility may solve a narrow need. Building it creates an ongoing responsibility for security, testing, support, and changes. Compare that full responsibility with buying an existing product.

Preserve room to change providers.

Keep evaluation cases, acceptance criteria, and business definitions separate from any one vendor’s interface. That gives the organization a basis for comparing new releases without rebuilding the meaning of the work each time.

What it means for operations

A useful pilot assigns a bounded job and specifies the result someone will accept.

Consider a weekly operating brief. The job includes collecting approved inputs, checking reporting periods, identifying material changes, preparing a concise draft, and flagging missing evidence. A manager reviews the result before distribution.

That is a more useful test than asking whether the latest model can write an impressive report. It reveals whether the system handles the routine cases, recognizes exceptions, and reduces total preparation effort.

Separate preparation from execution.

Reading records, proposing an action, changing a record, and sending a message are different responsibilities. Start by testing the reading and preparation stages. Grant action permissions only after the business has defined the approval process and tested the consequences.

Make exceptions part of the assignment.

Specify what happens when figures disagree, a source is missing, an instruction conflicts with policy, or a task reaches its budget limit. A completed workflow can include a correctly escalated exception. It does not always mean the agent finished every step.

Measure the accepted result.

Track preparation time, review time, corrections, completeness, and cost per accepted output. For recurring work, also track whether it arrives on schedule. These measures show whether the new capability improves the process or moves effort onto the reviewer.

The operating-brief example is a recommended pilot design, not a reported vendor or Stratenity deployment.

What it means for governance

The governance issue changes when an AI system can continue working, call tools, or access several business applications. Reviewing its answer is only part of the control environment. The organization also needs to know which actions it can take and under whose authority.

Independent evaluation at the model-provider level is valuable, but it does not establish whether a particular deployment works for your business. Local testing needs to cover your information, policies, permissions, and failure cases.

Similarly, a vendor’s privacy capability requires examination of the actual product and configuration. Check retention, connected applications, logging, and support access before treating a privacy announcement as a deployment assurance.

Practical ways to use the developments

These uses do not require access to every newly announced product. Many can be tested with an existing approved platform. New models and agents provide additional options; the business case depends on the task and the accepted result.

What to do over the next two weeks

1. Select one recurring responsibility. Choose a task with available evidence, a clear owner, and an accepted output. Avoid beginning with a broad instruction to automate a department.
2. Confirm access and terms. Check which released features your organization can use, which are previews, and which require additional licensing or usage charges.
3. Set the baseline and controls. Record current effort and quality. Define permitted sources, review requirements, exceptions, and spending limits.
4. Run a bounded comparison. Test the current process and candidate approach on representative cases, with human review.
5. Make an evidence-based decision. Expand, revise, or stop according to the accepted results and full operating cost.

For strategy, the recent changes expand the options for organizing and sourcing work. For operations, they create more ways to delegate bounded responsibilities. For governance, they make identity, permissions, evaluation, and spending controls part of everyday AI management.

Stratenity’s perspective is to bring these decisions together. A useful AI investment connects the business objective, the workflow, and the control environment before it expands.

How Stratenity Advisory helps: four steps from opportunity to operating capability

Start with a Strategy Scan, then move forward according to the evidence. Each step has a defined scope and a reviewable deliverable. Engagements are delivered by Stratenity Advisory through Stratenity’s Enterprise Strategic Execution (ESE) System.

Engagements start from $2,900. Scope, deliverables, timing, and fees are agreed before work begins, according to information readiness, integration complexity, and support requirements. The starting price does not imply that all four steps are included. Third-party licenses, cloud hosting, and model usage are additional unless expressly included. Timelines begin once required access and information are available.

A company can begin with the Scan and decide whether to proceed. The objective is a clear decision supported by evidence, followed by a capability that earns its place in daily work.

Stratenity Accepted into the NVIDIA Inception Program

We are pleased to announce that Stratenity has been accepted into the NVIDIA Inception program, which supports AI startups with technical resources, training, and access to NVIDIA’s ecosystem. [7]

We chose to join because NVIDIA’s enterprise AI ecosystem aligns with the portfolio we are building: AI that supports meaningful work, respects human judgment, and operates within clear boundaries. That alignment spans enterprise applications, open models, governance tools, and the digital health capabilities relevant to StratenHealth.

A role beyond GPUs

NVIDIA is widely associated with GPUs. We see a broader role in enterprise AI adoption and acceleration. Its portfolio includes inference services, open models, agent development tools, reference workflows, and industry-specific platforms. Together, these address the work between a promising model and a dependable business application. [8]

For Stratenity, the value is the ability to evaluate a connected set of building blocks across our products, rather than treating each AI feature as an isolated experiment. The NVIDIA Inception program gives us a route into technical resources, training, and the NVIDIA ecosystem as we develop that capability.

Alignment on responsible AI and human judgment

NVIDIA’s published trustworthy AI principles address privacy, safety and security, transparency, and nondiscrimination. We see alignment with Stratenity’s commitment to responsible, human-centered enterprise AI: people retain authority over consequential decisions, information has a defined purpose, and AI-supported work remains reviewable. [9]

That alignment has practical implications. We define what an AI system can access, which actions require approval, what evidence supports an output, and when it must stop or escalate. NVIDIA’s NeMo Guardrails offers programmable checks for model inputs and responses. Those checks complement the permissions, evaluations, and human review that we design around the work. [10]

Why open models matter to our portfolio

Open models and open-source tools provide options for specialization, evaluation, and deployment. NVIDIA Nemotron includes open models for reasoning, retrieval, speech, and safety. For Stratenity, that creates an opportunity to compare models on the actual task and select deployment arrangements suited to the organization’s information and operating requirements. [11]

Our approach remains selective. Model licenses, infrastructure costs, maintenance, and demonstrated performance determine where an open model fits. Access to a model is the beginning of the implementation decision.

How the technology aligns with our products

Our NVIDIA Inception program portfolio identifies technologies we are considering for VelorStrategy, the consulting portal, and the Stratenity Execution Model and Strategic Operating Graph. We are evaluating those choices against the work each product supports.

The portfolio entries identify technologies under consideration, rather than completed NVIDIA integrations. The mappings above explain their intended relevance; production choices will follow evaluation.

The relevance to StratenHealth

As we prepare the StratenHealth rollout, NVIDIA’s healthcare portfolio gives us a more specific development path than a general-purpose model alone. We are aligning the technology evaluation to each intended health workflow, its information requirements, and the people responsible for reviewing it.

NVIDIA’s digital health material places Nemotron and NeMo directly in this application context. Its Digital Health Developers Program brings together technologies, sample code, education, and training. We see that program as a relevant next step to explore as we prepare StratenHealth. [14] [15]

MONAI remains relevant to separately defined medical imaging work, and BioNeMo to biology and drug discovery. These are specialist paths within NVIDIA’s wider healthcare portfolio; the digital health direction described here centers on documentation, engagement, navigation, and operations. [14]

Our rollout approach is to define the workflow, establish the evidence and review requirements, compare candidate technologies, and advance the applications that meet the agreed standard. Clinical decisions retain appropriate professional accountability.

EXPLORE STRATENHEALTH → · Discuss enterprise AI and healthcare with us

Sincerely,
Dodi

Dr. Dodi Mossafer, DBA
Founder, Stratenity
advisory@velorstrategy.com · stratenity.com